Hassan R - Search Results

1

New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.

Mossman BT, Shukla A, Heintz NH, Verschraegen CF, Thomas A, Hassan R. Mossman BT, et al. Among authors: hassan r. Am J Pathol. 2013 Apr;182(4):1065-77. doi: 10.1016/j.ajpath.2012.12.028. Epub 2013 Feb 8. Am J Pathol. 2013. PMID: 23395095 Free PMC article. Review.

2

Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.

Li Q, Verschraegen CF, Mendoza J, Hassan R. Li Q, et al. Among authors: hassan r. Anticancer Res. 2004 May-Jun;24(3a):1327-35. Anticancer Res. 2004. PMID: 15274292 Free article.

3

Immunotherapies for non-small-cell lung cancer and mesothelioma.

Thomas A, Hassan R. Thomas A, et al. Among authors: hassan r. Lancet Oncol. 2012 Jul;13(7):e301-10. doi: 10.1016/S1470-2045(12)70126-2. Epub 2012 Jun 28. Lancet Oncol. 2012. PMID: 22748269 Free PMC article. Review.

4

Farletuzumab in lung cancer.

Thomas A, Maltzman J, Hassan R. Thomas A, et al. Among authors: hassan r. Lung Cancer. 2013 Apr;80(1):15-8. doi: 10.1016/j.lungcan.2012.12.021. Epub 2013 Jan 26. Lung Cancer. 2013. PMID: 23357463 Free PMC article. Review.

5

Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression.

Hassan R, Miller AC, Sharon E, Thomas A, Reynolds JC, Ling A, Kreitman RJ, Miettinen MM, Steinberg SM, Fowler DH, Pastan I. Hassan R, et al. Sci Transl Med. 2013 Oct 23;5(208):208ra147. doi: 10.1126/scitranslmed.3006941. Sci Transl Med. 2013. PMID: 24154601 Free PMC article. Clinical Trial.

6

Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma.

Kalra N, Zhang J, Thomas A, Xi L, Cheung M, Talarchek J, Burkett S, Tsokos MG, Chen Y, Raffeld M, Miettinen M, Pastan I, Testa JR, Hassan R. Kalra N, et al. Among authors: hassan r. BMC Cancer. 2015 May 8;15:376. doi: 10.1186/s12885-015-1362-2. BMC Cancer. 2015. PMID: 25952750 Free PMC article.

7

Antibody-drug conjugates for cancer therapy.

Thomas A, Teicher BA, Hassan R. Thomas A, et al. Among authors: hassan r. Lancet Oncol. 2016 Jun;17(6):e254-e262. doi: 10.1016/S1470-2045(16)30030-4. Lancet Oncol. 2016. PMID: 27299281 Free PMC article. Review.

8

Malignant Mesothelioma Effusions Are Infiltrated by CD3⁺ T Cells Highly Expressing PD-L1 and the PD-L1⁺ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody Avelumab.

Khanna S, Thomas A, Abate-Daga D, Zhang J, Morrow B, Steinberg SM, Orlandi A, Ferroni P, Schlom J, Guadagni F, Hassan R. Khanna S, et al. Among authors: hassan r. J Thorac Oncol. 2016 Nov;11(11):1993-2005. doi: 10.1016/j.jtho.2016.07.033. Epub 2016 Aug 17. J Thorac Oncol. 2016. PMID: 27544053 Free PMC article.

9

Mesothelin Immunotherapy for Cancer: Ready for Prime Time?

Hassan R, Thomas A, Alewine C, Le DT, Jaffee EM, Pastan I. Hassan R, et al. J Clin Oncol. 2016 Dec;34(34):4171-4179. doi: 10.1200/JCO.2016.68.3672. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27863199 Free PMC article. Review.

10

Clinical Features and Outcomes of Tunica Vaginalis Mesothelioma: A Case Series From the National Institutes of Health.

An JY, Kim D, Tanakchi S, Semerjian AM, Thomas A, Boyle SL, Hassan R, Metwalli AR. An JY, et al. Among authors: hassan r. Clin Genitourin Cancer. 2017 Oct;15(5):e871-e875. doi: 10.1016/j.clgc.2017.04.022. Epub 2017 May 22. Clin Genitourin Cancer. 2017. PMID: 28606736 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,107 results

Search Page